TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, announced that it has entered into a research agreement with Centre Léon Bérard, which provides the framework for molecular profiling studies aimed to advance precision medicine. The initial project utilizes the HTG EdgeSeq Oncology Biomarker Panel to retrospectively […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a master services agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for work to be performed in HTG’s VERI/O laboratory. The initial project includes the development of a custom assay for the detection […]

Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC, which is expected to […]

CULVER CITY, Calif. — NantOmics, the leader in molecular diagnostics and a member of the NantWorks ecosystem of families, announced today the acquisition of Genos, the leading community for next-generation sequencing, personal genetic discovery and research, based in San Francisco. Genos was spun out of Complete Genomics in 2016 and quickly has become the leader in making […]

Automated Whole-Genome Sequencing Approach Provides Confidence in Results with Increased Sample Throughput and Decreased Turnaround Time Reno, Nev. – Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (NGS) workflow is a simple six-step […]

CAMBRIDGE, Mass.—-Seven Bridges, the biomedical data analysis company, today announced that it has made the Simons Genome Diversity Project (SGDP) dataset available for analysis by researchers via the Seven Bridges Platform. The SGDP is the largest dataset of human genetic variation ever collected, including whole genomes from 300 individuals representing 142 diverse populations across the […]

BASEL, Switzerland—-ChemChina and Syngenta today announced that they have received approval from the Ministry of Commerce of the People’s Republic of China (MOFCOM) for the proposed acquisition of Syngenta by ChemChina. This represents a further step towards the closing of the transaction, which is expected to take place in the second quarter of 2017. The […]

CAMBRIDGE, Mass. –Seven Bridges, the biomedical data analysis company, today announced that it has made the Simons Genome Diversity Project (SGDP) dataset available for analysis by researchers via the Seven Bridges Platform. The SGDP is the largest dataset of human genetic variation ever collected, including whole genomes from 279 individuals representing 130 diverse populations across the globe. […]

NEW YORK — The Human Vaccines Project and Vanderbilt University Medical Center today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system. Illumina will provide the genetic sequencing technologies and expertise required to process the massive amounts of data required to decode the human immunome. The […]

– Integration completed in under three months – Local SYGNIS and C.B.S. sites in San Diego consolidated – CBS products now also sold through SYGNIS direct sales force Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the successful completion of the integration of C.B.S. Scientific Company Inc. […]